EDISON ONCOLOGY
Edison Oncology develops and commercializes new therapies for cancer patients and their families. The company was founded in 2018 by Jeffrey Bacha and is headquartered in Menlo Park, California, United States.
EDISON ONCOLOGY
Industry:
Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.edisononcology.com
Status:
Active
Contact:
650-690-1927
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Amazon ReCAPTCHA GoDaddy DNS
Similar Organizations
Affini-T Therapeutics
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Cancer & Hematology Centers of Western Michigan
Cancer & Hematology Centers of Western Michigan is dedicated to help, healing and hope for cancer patients and their families.
Cashel Neural
Cashel Neural develops and commercializes novel therapies for multiple sclerosis.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
OncoGenex
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Founder
Official Site Inspections
http://www.edisononcology.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.32 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Edison Oncology"
About - Edison Oncology Holding Corp
Company Information - Edison Oncology Holding Corp
Investor Relations Counsel Amato and Partners LLC New York / San Diego T: (212) 430-0360 [email protected] amatoandpartners.comSee details»
Edison Oncology - Crunchbase Company Profile & Funding
Edison Oncology develops and commercializes new therapies for cancer patients and their families. The company was founded in 2018 by Jeffrey Bacha and is headquartered in Menlo …See details»
EDISON ONCOLOGY HOLDING CORP. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EDISON ONCOLOGY HOLDING CORP. of Menlo Park, CA. Get the latest business insights from Dun …See details»
Edison Oncology Holding - Overview, News & Similar companies
Apr 19, 2023 Edison Oncology Holding contact info: Phone number: (650) 690-1927 Website: www.edisononcology.com What does Edison Oncology Holding do? Edison Oncology was …See details»
Edison Oncology - VentureRadar
Website: https://www.edisononcology.com/ Develops and commercializes new cancer therapies, leveraging deep understanding of cancer biology and pharmacology to improve ...See details»
Edison Oncology - PitchBook
Publication ID Patent Title Status First Filing Date Technology (CPC) Citations; AU-2022370861-A1: Compositions and methods for treatment of hyperproliferative, inflammatory, and …See details»
Leadership Team - Edison Oncology Holding Corp
Dr. Sankar received his training in clinical research and tumor biology from NCI Bethesda, Maryland and since has held clinical development positions within leading Biotech/Pharma …See details»
Edison Oncology Reports Promising Interim Data from Ongoing …
Apr 8, 2024 Edison Oncology Holding Corp. ("Edison Oncology"), a privately held biopharmaceutical company, today announced the presentation of positive interim data from …See details»
Edison Oncology and Apollomics Inc. Announce Treatment of First …
Jan 4, 2022 MENLO PARK, Calif., FOSTER CITY, Calif. and HANGZHOU, China, September 30, 2021 – Edison Oncology Holding Corp. (“Edison Oncology”), a company established to …See details»
Edison Oncology Announces Treatment of First Patient in …
Feb 17, 2022 Further information can be found at www.edisononcology.com. Company Contact: Jeffrey Bacha Chief Executive Officer [email protected] Investor Relations Contact: Amato & …See details»
Recommended Stories
Sep 30, 2021 MENLO PARK, Calif., FOSTER CITY, Calif. and HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Edison Oncology Holding Corp. (“Edison Oncology”), a …See details»
Edison Oncology Partners DNA-damage Response Inhibitor
MENLO PARK, Calif., March 31, 2021 /PRNewswire/ -- Edison Oncology Holding Corp. ("Edison Oncology"), a company established to develop and commercialize new therapies targeting the …See details»
Investor Relations :: Edison Oncology Holding Corp
We are developing a pipeline of unique small-molecule product candidates, each with several “shots on goal” in both orphan and major cancer markets. Our goal is address shortcomings of …See details»
Edison Oncology Partners DNA-damage Response Inhibitor …
MENLO PARK, Calif., March 31, 2021 /PRNewswire/ -- Edison Oncology Holding Corp. ("Edison Oncology"), a company established to develop and commercialize new therapies targeting the …See details»
Contact - Edison Oncology Holding Corp
Address. 3475 Edison Way Suite R Menlo Park, CA 94025 First Name. Last NameSee details»
Edison Oncology Reports Promising Interim Data from Ongoing …
MENLO PARK, Calif., April 8, 2024 /PRNewswire/ -- Edison Oncology Holding Corp. ("Edison Oncology"), a privately held biopharmaceutical company, today announced the presentation of …See details»
Press Releases - Edison Oncology Holding Corp
Feb 10, 2021 We are developing a pipeline of unique small-molecule product candidates, each with several “shots on goal” in both orphan and major cancer markets. Our goal is address …See details»